Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) Director Eric Andersen acquired 134,493 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The shares were acquired at an average cost of $12.00 per share, for a total transaction of $1,613,916.00. Following the purchase, the director now directly owns 1,496,680 shares […]
Merrimack Pharmaceuticals (NASDAQ:MACK) Downgraded by StockNews.com to Sell etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a sell rating to a hold rating in a research report released on Saturday morning. Merrimack Pharmaceuticals Stock Up 0.3 % MACK opened at $12.81 on Friday. The firm has a market capitalization of $182.67 million, a P/E ratio of -106.75 and a beta […]
Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) was upgraded by stock analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued on Saturday. Merrimack Pharmaceuticals Price Performance Merrimack Pharmaceuticals stock opened at $12.50 on Friday. The stock has a market cap of $178.25 million, a P/E ratio of -104.17 and […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.